Ge Healthcare
Clinical trials sponsored by Ge Healthcare, explained in plain language.
-
New ultrasound dye could help spot Kids' liver tumors earlier
Diagnosis Recruiting nowThis study is testing whether a special ultrasound contrast agent called Sonazoid can help doctors better tell apart benign (non-cancerous) and malignant (cancerous) liver masses in children. About 50 children under 18 with a liver mass will receive an injection of Sonazoid durin…
Phase: PHASE4 • Sponsor: GE Healthcare • Aim: Diagnosis
Last updated May 01, 2026 16:01 UTC
-
New imaging agent could reveal if immunotherapy is working
Diagnosis Recruiting nowThis early-phase study is testing a new imaging agent (GEH200520/GEH200521) that uses PET scans to visualize solid tumors. In Part A, researchers check the safety of the agent in 50 adults with advanced cancer. In Part B, they see if the agent can show changes in tumors before an…
Phase: PHASE1 • Sponsor: GE Healthcare • Aim: Diagnosis
Last updated May 01, 2026 15:59 UTC